ZZV-25363-91825
2 vaccinations
6 coded responses
13 check-ins
6 free-text entries
4 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 100 / NY
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-18
Dose 1 — Pfizer-BioNTech
-
2021-02-22
Registered in v-safe
-
2021-02-25
Survey response — day 7, dose 1MedDRA: Seizure — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to workFree text: SeizureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
-
2021-03-10
Dose 2 — Pfizer-BioNTech
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-15
Survey response — days 1–6 daily, dose 2MedDRA: Seizure — Feeling: Fair · Fatigue or tirednessFree text: SeizureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
-
2021-03-17
Health check-in — day 7, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-25
-
2021-04-02
Survey response — day 21, dose 2MedDRA: Blood test, Cataract, Echocardiogram, Hypercalcaemia, Hyperparathyroidism, Office visit, Scan myocardial perfusion, Ultrasound scan — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Hypercalcimium, hyper parathyroidism , developing cataracts · Healthcare visit (other): Multiple blood tests, multiple eye studies, ultrasound study, echocardiogram, scheduled for nuclear medicine study, MRIMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-10
Survey response — day 28, dose 2MedDRA: Echocardiogram, Hypercalcaemia, Hyperparathyroidism, Laboratory test, Magnetic resonance imaging, Ultrasound scan, Unevaluable event — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Hypercalcimum secondary to hyper parathyroidism · Healthcare visit (other): MRI, echo cardio gram, ultrasound of kidneys, labsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Report sent to call center — day 28, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-14
-
2021-04-21
Survey response — day 42, dose 2MedDRA: Blood calcium increased, Blood parathyroid hormone increased, Hypercalcaemia, Hyperparathyroidism, Office visit, Parathyroid gland enlargement — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Hyper parathyroidism,hyper calcium, high PTH. · Healthcare visit (other): Visit to head and neck surgeon; more labsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-10
- 2021-06-11
-
2021-09-08
Survey response — 6 months, dose 2MedDRA: Decreased appetite, Dyspnoea, Headache — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Shortness of breath, headache, loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-08
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech |
Call center
4 call center cases
4 unsuccessful
Free text
Release 4 — day 7, dose 1
Systemic reaction (other): Seizure
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Seizure
Release 6 — day 21, dose 2
Symptoms: Hypercalcimium, hyper parathyroidism , developing cataracts
Healthcare visit (other): Multiple blood tests, multiple eye studies, ultrasound study, echocardiogram, scheduled for nuclear medicine study, MRI
Release 7 — day 28, dose 2
Symptoms: Hypercalcimum secondary to hyper parathyroidism
Healthcare visit (other): MRI, echo cardio gram, ultrasound of kidneys, labs
Release 7 — day 42, dose 2
Symptoms: Hyper parathyroidism,hyper calcium, high PTH.
Healthcare visit (other): Visit to head and neck surgeon; more labs
Release 9 — 6 months, dose 2
Symptoms: Shortness of breath, headache, loss of appetite
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Blood test | ○ | ✓ | ○ |
| HCVO | Echocardiogram | ✓ | ✓ | ○ |
| HCVO | Laboratory test | ✓ | ✓ | ○ |
| HCVO | Magnetic resonance imaging | ✓ | ✓ | ○ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Scan myocardial perfusion | ○ | ✓ | ○ |
| HCVO | Ultrasound scan | ✓ | ✓ | ○ |
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Blood calcium increased | ○ | ✓ | ○ |
| SD | Blood parathyroid hormone increased | ✓ | · | ✓ |
| SD | Cataract | ✓ | ✓ | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypercalcaemia | ✓ | ✓ | ✓ |
| SD | Hyperparathyroidism | ✓ | ✓ | ✓ |
| SD | Parathyroid gland enlargement | ○ | ✓ | ○ |
| SRO | Seizure | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release